Denmark's Novo Nordisk invests €2.1 billion in France
  • 5 months ago
Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.
Recommended